The authors concluded that 70% of their 111 cases were either LMP1 over-expressed or contained significant NF-κB pathway negative regulator mutations (loss-of-function), suggesting that the NF-κB pathway activation is strongly implicated in driving a majority of EBV+ NPC. Here, NFKB1 is linked to nasopharyngeal carcinoma.